Solutions for
Early Phase Research
Advarra provides accelerated review timelines, specialized support, and intuitive technology tailored to early phase studies. Our expertise ensures even the most time-sensitive phase I trials proceed smoothly and efficiently.
Essential Offerings
- Reliable IRB timelines
- Specialized oncology expertise
- Efficient consent form development
- Integrated technology workflows
Support for Early Phase Research
Reliable IRB Reviews
Advarra’s IRB offers quick and dependable review timelines keeping your studies on schedule.
Clinical Conductor
Built for the complexities of early-phase research, Clinical Conductor Clinical Trial Management System (CTMS) supports participant recruitment and streamlines trial management, enhancing efficiency.
Integrated Technology
Systems like Advarra’s eSource and eRegulatory (eReg) Management System eliminates duplicative work by integrating seamlessly into your trial processes, improving data quality and regulatory workflows.
Oncology and Genetics
Our teams provide the nuanced support needed for phase I oncology and genetic engineering studies, ensuring compliance and rapid startup.
Informed Consent Development
Dramatically reduce development time to completion while ensuring phase I-specific compliance, providing fully developed IRB-ready ICFs in 3-5 days on average.
Staffing Support
Our short- and long-term research staffing solutions ensure you have the expertise needed to maintain momentum throughout your trial.
Turnaround Times
days
New protocol and consent
(full board review)
days
New site
days
Amendments and modifications
(full board review)
days
Recruitment and subject-facing materials
Turnaround times reflect complete submission to IRB document distribution. Please note: Turnaround time is dependent upon complete and accurate submission of study documents. Any follow up requiring a response may extend this turnaround time.
